James P. Kelly

EVP, Chief Financial Officer and TreasureratNovavax· In proxies 2021–2025

Pay in FY2025+63% from the year before · Novavax stock -16.4% the same year

James P. Kelly was paid $3.0M in FY2025 (Dec), up 63%. Novavax stock fell 16.4% that year.

Pay$100 in the stock at the end of FY20 → $6

Pay is from the Summary Compensation Table of each Novavax proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

NVAX
NovavaxPublic company · 5 yr
- EVP, Chief Financial Officer and Treasurer2021 – Present · 5 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

Pay
Novavax CFO pay rose 63% to $3.0M. The stock fell 16% in FY2025 (Dec).
DEF 14AApr 27, 2026
Pay
Novavax CFO pay rose 22% to $1.8M. The stock rose 68% in FY2024 (Dec).
DEF 14AApr 29, 2025
Pay
Novavax CFO pay fell 35% to $3.2M. The stock fell 93% in FY2022 (Dec).
DEF 14AApr 29, 2025
Pay
Novavax CFO pay fell 53% to $1.5M. The stock fell 53% in FY2023 (Dec).
DEF 14AApr 29, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?